CD2 and small cell lung carcinoma: We also observed increased expression levels of immune‐related genes, such as SLAMF7, TNFSF8, BTN3A1, CD2, LGALS9, PRF1, and MX2, in tumor samples from the MT group of the Local‐SCLC cohort (Figure 3h–n).